Literature DB >> 17904065

Use of an optimized transient occlusion of the middle cerebral artery protocol for the mouse stroke model.

Zahoor Ahmad Shah1, Khodadad Namiranian, Judy Klaus, Kathy Kibler, Sylvain Doré.   

Abstract

Intraluminal occlusion of the middle cerebral artery in rodents is widely used for investigating cerebral ischemia and reperfusion injury. Two types of filaments used for occlusion were tested in terms of surgical success, incidence of subarachnoid hemorrhage, and mortality: a standard 6-0 monofilament coated with methyl methacrylate glue (rigid probe) and an 8-0 monofilament coated with silicone (flexible probe). In 98 wild-type (WT) mice, the flexible probe produced significantly (P < .05) more successful strokes (73.5%) than the rigid probe (46.6%). The incidences of subarachnoid hemorrhage (3.7%) and mortality (5.6%) with the flexible probe were significantly lower than those with the rigid probe (26.6% and 11.1%, respectively). Rigid and flexible probes were also compared in heme oxygenase 1 knockout (n = 17) and WT littermates (n = 17), because knockout mice have been suggested to have more fragile blood vessels. All mice receiving the flexible probe had successful strokes, with no cases of subarachnoid hemorrhage or mortality; however, with the rigid probe, the success rate was only 80% in the WT mice and 60% in the knockout mice. The rates of subarachnoid hemorrhage and mortality were also significantly higher with the rigid probe in both genotypes, but the infarct volumes produced by each type of probe did not differ significantly between the 2 groups. We conclude that the flexible silicone-coated 8-0 probe is superior to the more rigid glue-coated probe, because it produces infarct volumes of equal size with a higher success rate and lower risk of subarachnoid hemorrhage and mortality.

Entities:  

Year:  2006        PMID: 17904065     DOI: 10.1016/j.jstrokecerebrovasdis.2006.04.002

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  25 in total

1.  Preconditioning with Ginkgo biloba (EGb 761®) provides neuroprotection through HO1 and CRMP2.

Authors:  Shadia E Nada; Zahoor A Shah
Journal:  Neurobiol Dis       Date:  2012-01-24       Impact factor: 5.996

2.  Stimulation of prostaglandin E2-EP3 receptors exacerbates stroke and excitotoxic injury.

Authors:  Muzamil Ahmad; Abdullah Shafique Ahmad; Hean Zhuang; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  J Neuroimmunol       Date:  2007-02-02       Impact factor: 3.478

3.  Neuroprotective properties of prostaglandin I2 IP receptor in focal cerebral ischemia.

Authors:  S Saleem; Z A Shah; T Maruyama; S Narumiya; S Doré
Journal:  Neuroscience       Date:  2010-07-14       Impact factor: 3.590

4.  The flavanol (-)-epicatechin prevents stroke damage through the Nrf2/HO1 pathway.

Authors:  Zahoor A Shah; Rung-chi Li; Abdullah S Ahmad; Thomas W Kensler; Masayuki Yamamoto; Shyam Biswal; Sylvain Doré
Journal:  J Cereb Blood Flow Metab       Date:  2010-05-05       Impact factor: 6.200

5.  Microsomal prostaglandin E synthase-1 contributes to ischaemic excitotoxicity through prostaglandin E2 EP3 receptors.

Authors:  Y Ikeda-Matsuo; H Tanji; A Ota; Y Hirayama; S Uematsu; S Akira; Y Sasaki
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

6.  Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1.

Authors:  Yoshihito Sakata; Hean Zhuang; Herman Kwansa; Raymond C Koehler; Sylvain Doré
Journal:  Exp Neurol       Date:  2010-04-08       Impact factor: 5.330

7.  RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).

Authors:  Shimin Liu; Gehua Zhen; Bruno P Meloni; Kym Campbell; H Richard Winn
Journal:  J Exp Stroke Transl Med       Date:  2009-01-01

8.  The edaravone and 3-n-butylphthalide ring-opening derivative 10b effectively attenuates cerebral ischemia injury in rats.

Authors:  Kai Hua; Xiao Sheng; Ting-ting Li; Lin-na Wang; Yi-hua Zhang; Zhang-jian Huang; Hui Ji
Journal:  Acta Pharmacol Sin       Date:  2015-06-15       Impact factor: 6.150

9.  PHLPP1 gene deletion protects the brain from ischemic injury.

Authors:  Bo Chen; Jessica A Van Winkle; Patrick D Lyden; Joan H Brown; Nicole H Purcell
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-17       Impact factor: 6.200

10.  Low doses of carbon monoxide protect against experimental focal brain ischemia.

Authors:  Emil Zeynalov; Sylvain Doré
Journal:  Neurotox Res       Date:  2009-02-21       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.